Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2017 3
2018 3
2020 2
2021 3
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Harnessing natural killer cells for the treatment of ovarian cancer.
Hoogstad-van Evert JS, Bekkers R, Ottevanger N, Jansen JH, Massuger L, Dolstra H. Hoogstad-van Evert JS, et al. Gynecol Oncol. 2020 Jun;157(3):810-816. doi: 10.1016/j.ygyno.2020.03.020. Epub 2020 Apr 5. Gynecol Oncol. 2020. PMID: 32268953 Free article. Review.
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer.
Maas RJA, Hoogstad-van Evert JS, Hagemans IM, Brummelman J, van Ens D, de Jonge PKJD, Hooijmaijers L, Mahajan S, van der Waart AB, Hermans CKJC, de Klein J, Woestenenk R, van Herwaarden AE, Schaap NPM, Rezaeifard S, Tauriello DVF, Zusterzeel PLM, Ottevanger N, Jansen JH, Hobo W, Dolstra H. Maas RJA, et al. Among authors: hoogstad van evert js. Front Immunol. 2024 Sep 23;15:1448041. doi: 10.3389/fimmu.2024.1448041. eCollection 2024. Front Immunol. 2024. PMID: 39376560 Free PMC article.
CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice.
Van der Meer JMR, de Jonge PKJD, van der Waart AB, Geerlings AC, Moonen JP, Brummelman J, de Klein J, Vermeulen MC, Maas RJA, Schaap NPM, Hoogstad-van Evert JS, Ottevanger PB, Jansen JH, Hobo W, Dolstra H. Van der Meer JMR, et al. Among authors: hoogstad van evert js. Oncoimmunology. 2021 Oct 1;10(1):1981049. doi: 10.1080/2162402X.2021.1981049. eCollection 2021. Oncoimmunology. 2021. PMID: 34616589 Free PMC article.
The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
van Lith SAM, van den Brand D, Wallbrecher R, Wübbeke L, van Duijnhoven SMJ, Mäkinen PI, Hoogstad-van Evert JS, Massuger L, Ylä-Herttuala S, Brock R, Leenders WPJ. van Lith SAM, et al. Among authors: hoogstad van evert js. Eur J Pharm Biopharm. 2018 Mar;124:63-72. doi: 10.1016/j.ejpb.2017.12.009. Epub 2017 Dec 20. Eur J Pharm Biopharm. 2018. PMID: 29274374 Free article.
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
Maas RJ, Hoogstad-van Evert JS, Van der Meer JM, Mekers V, Rezaeifard S, Korman AJ, de Jonge PK, Cany J, Woestenenk R, Schaap NP, Massuger LF, Jansen JH, Hobo W, Dolstra H. Maas RJ, et al. Among authors: hoogstad van evert js. Oncoimmunology. 2020 Nov 8;9(1):1843247. doi: 10.1080/2162402X.2020.1843247. Oncoimmunology. 2020. PMID: 33224630 Free PMC article.
16 results